This product is used for the in vitro qualitative detection of Influenza A and B virus antigens in human nasal swab and throat swab samples.
• Rapid & Clear
Delivers readable results in 1-10 minutes.
• High Clinical Concordance
Proven highly accurate in clinical evaluations, achieving an overall concordance rate of over 98% for both Influenza A and Influenza B.
• No Cross-Reactivity
Exhibits no cross-reactivity with other common respiratory pathogens, including SARS-CoV, MERS-CoV, novel coronavirus (2019-nCoV), and respiratory syncytial virus.
• Strong Anti-Interference
Test results are not disrupted by common medications like oseltamivir or zanamivir, and resist interference from endogenous substances such as mucin and blood.
Test Principle | Colloidal gold immunochromatography |
Specimen Type | Nasal swab and throat swab |
Sample Volume | 4 drops (approx. 100 µL) for cards |
Reaction Time | 1-10 minutes |
Storage Conditions | 2-30°C |
Shelf Life | 24 months |
Cat. No. | Product Name | Spec. |
E1101 | ERLIA Flu A/B Ag (Cassette) | 1 tests/kit |
E1102 | 5 tests/kit | |
E1103 | 20 tests/kit | |
E1104 | 40 tests/kit | |
E1111 | ERLIA Flu A/B Ag (Strip )
| 20 tests/kit |
E1112 | 30 tests/kit | |
E1113 | 40 tests/kit |